# Scinopharm Taiwan Ltd – FDA Inspection, May 17, 2019

Source: https://www.keypedia.com/records/fda_inspections/scinopharm-taiwan-ltd/7044bf7c-e911-4e7c-84ce-056f5f8b6169
Source feed: FDA_Inspections

> FDA inspection 1094253 of Scinopharm Taiwan Ltd, May 17, 2019. Classification: No Action Indicated (NAI). 7 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1094253
- Company Name: Scinopharm Taiwan Ltd
- Inspection Date: 2019-05-17
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- [FDA Inspection 1326554 - 2026-06-23](https://www.keypedia.com/records/fda_inspections/scinopharm-taiwan-ltd/606f497d-2e69-48a2-a0c3-3e55958eae0f)
- FDA Inspection 1235581 - 2024-03-21
- FDA Inspection 1191835 - 2022-10-25
- FDA Inspection 1004952 - 2017-02-10
- FDA Inspection 921134 - 2015-03-27

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/joshua-p-wireman/1f5cca58-4a35-4b1a-b344-35820b1e58fb)

Company: https://www.keypedia.com/companies/scinopharm-taiwan-ltd/fe461fae-c096-4537-985b-2caeeebda3a1

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c